Stockholm, Sweden

Egon R Diczfalusy

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Egon R Diczfalusy. Retrieved from https://idiyas.com/inventor/egon-r-diczfalusy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Egon R Diczfalusy

Introduction

Egon R Diczfalusy is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of long-acting androgenic compounds. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Diczfalusy holds a patent for "Long-acting androgenic compounds and pharmaceutical compositions thereof." This patent describes long-acting androgenic compositions that comprise C.sub.4 -C.sub.6 cycloalkyl carboxylic acids of testosterone and a pharmaceutically acceptable carrier medium. The invention allows the ester to be dissolved in an acceptable oily medium or suspended in an aqueous medium in the form of micronised particles or milled particles. This innovation represents a significant advancement in the formulation of androgenic therapies.

Career Highlights

Throughout his career, Diczfalusy has focused on the intersection of chemistry and medicine. His research has contributed to the understanding and development of androgenic compounds, which are crucial for various therapeutic applications. His work has been recognized within the scientific community, and he continues to be an influential figure in his field.

Collaborations

Diczfalusy has collaborated with notable individuals such as Josef Fried and Pierre Crabbe, both of whom have made their own contributions to the field. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Egon R Diczfalusy's work in the development of long-acting androgenic compounds highlights the importance of innovation in pharmaceuticals. His contributions continue to influence the field and pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…